News

CPS Technologies Corp Reports Positive Financial Trends for Q4

CPS Technologies Corp Reports Positive Financial Trends for Q4

CPS Technologies Corporation Reports Fourth Quarter Results

CPS Technologies Corporation (NASDAQ: CPSH) has announced its financial results for the fiscal fourth quarter ending December 28, 2024. The company experienced notable developments in its operations, providing a positive outlook for the future.

Fourth Quarter Financial Performance

CPS Technologies reported a revenue of $5.9 million for the fourth quarter, a decrease from $6.7 million in the same quarter last year. Despite the decline year-over-year, there was a significant increase compared to the previous quarter, owing to higher production rates and a surge in customer shipments.

Key Factors Contributing to Revenue Fluctuation

The drop in revenue can be attributed to the completion of the HybridTech Armor contract with Kinetic Protection for the U.S. Navy. However, the recent production enhancements and fulfillment of additional contracts, including three Phase I SBIR contracts funded by the U.S. Army, have helped bolster revenue streams from new product lines.

Product Innovations and Market Expansion

CPS Technologies recently made headlines with its first commercial sale of radiation shielding materials, signaling a strategic diversification in its product offerings. These new advancements highlight the company's commitment to maintaining innovative solutions in high-performance materials.

Outlook for 2025

Looking ahead, Brian Mackey, President and CEO, expressed optimism as the company aims to leverage its unique material capabilities. The anticipated growth in military and commercial applications indicates that CPS is set to expand its market presence significantly.

Operational Challenges and Financial Overview

In terms of operational costs, CPS reported a gross loss of $0.3 million or (4.6) percent of revenue for the quarter. This was in contrast to a gross profit of $1.1 million from the prior year. The challenges included training costs and expenses linked to increasing production, which had adverse effects on profitability during the transition period.

Understanding the Financial Metrics

On the operational front, the company recorded a loss of $1.3 million for the quarter compared to a profit in the same quarter last year. Notably, the net loss was reported at $1.0 million or $(0.07) per diluted share.

Upcoming Earnings Call

To discuss these results and the company's future direction, CPS Technologies will host an earnings call. Investors are encouraged to participate in this event as a means to gain further insights into the company's performance and strategies.

About CPS Technologies

CPS Technologies is recognized for its development of high-performance material solutions applicable across various sectors, including electric vehicles, renewable energy, and military applications. Committed to innovation, CPS aims to facilitate the shift to clean energy and modern technological advancements.

Frequently Asked Questions

1. What were the key factors affecting CPS Technologies' Q4 revenue?

The revenue drop was mainly due to the conclusion of the HybridTech Armor contract while higher production rates positively influenced revenue compared to the previous quarter.

2. How did CPS Technologies perform compared to last year?

While the Q4 revenue of $5.9 million is lower than the previous year's $6.7 million, there was a notable sequential increase from the prior quarter.

3. What are some recent developments for CPS Technologies?

The company announced its first commercial sale of radiation shielding and secured additional Army SBIR contracts, marking significant growth in its product offerings.

4. What is the outlook for CPS Technologies in 2025?

The company is positioning itself for strong revenue growth and aims for profitability through increased demand for its core products and new market opportunities.

5. How can investors participate in the next CPS earnings call?

Investors can dial into the earnings call scheduled to discuss the company's performance and future strategies; details will be available on their website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 37

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 96

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 58

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 76

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 58

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Heart and Kidney Health Through Collaboration

Updated Category News Views 264

Collaboration for Health Awareness In an exciting development, the American Kidney Fund (AKF) has forged a partnership with the American Heart Association (AHA) as part of their Cardiovascular-Kidney-Metabolic Health Initiative™. This collaboration aims to raise awareness regarding the crucial link between kidney disease and cardiovascular conditions, both of which...

Continue Reading
Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown

Updated Category News Views 106

Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown Kering (EPA: PRTP) has recently experienced a shift in market sentiment as analysts express increasing caution regarding its performance. TD Cowen has notably lowered its price target for Kering to €230 from €260, while sustaining a Hold rating for the stock. The adjustment signals growing concerns...

Continue Reading
Xi Jinping Champions Common Development at G20 Summit

Updated Category News Views 308

Xi Jinping's Vision for Global Cooperation at the G20 Summit Chinese President Xi Jinping recently made headlines during a significant gathering known as the G20 Summit. His participation underscored a strong commitment to fostering global cooperation and development, marking a notable moment in international relations. Advocating for a Unified Approach During his...

Continue Reading
OHA Secures Financing for Onex's Acquisition of Farsound

Updated Category News Views 84

OHA Leads Innovative Financing for Strategic Acquisition In a significant development in the financial world, Oak Hill Advisors (OHA) has taken on the role of Lead Left Arranger for a private unitranche financing aimed at supporting the acquisition of Farsound Aviation Limited by Onex. Farsound stands out in the aerospace engine maintenance, repair, and overhaul (MRO)...

Continue Reading
Zentalis Pharmaceuticals Rebounds After FDA Clearance for Azenosertib

Updated Category News Views 75

Zentalis Pharmaceuticals Advances with Azenosertib Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), located in San Diego, has some exciting updates for its stakeholders. The U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the company's studies involving azenosertib. This is fantastic news, as it enables Zentalis to restart patient enrollment...

Continue Reading